Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

Clinical trial NCT01002274 · COMPLETED

Trial details

NCT number: NCT01002274
Sponsor: Health Ever Bio-Tech Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lower Urinary Tract Symptoms Benign Prostatic Hyperplasia

Start date: 2010-08-01
Primary completion: 2014-06-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.